GlassScriptPhysician profile
Eduardo Rodriguez
NPI 1598959066
$2,001.27
in general payments reported to CMS, 2019-2025
9 companies · $792 in 2025
The $792 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $761 · 2023: $323 · 2024: $125 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835 · Travel and Lodging: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.24 |
| Travel and Lodging | $405.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $919.17 | 2022-2023 | Mars Anterior Retractor |
| W. L. Gore & Associates, INC. | $756.94 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Terumo Medical Corporation | $110.28 | 2024 | Azur Cx Detachable |
| Kci USA, INC. | $85.56 | 2023 | Bair Paws, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Dilon Technologies, INC. | $50.88 | 2023 | Hemoblast Bellows |
| Boston Scientific Corporation | $28.65 | 2023 | Watchman Access System |
| Cvrx, INC. | $21.88 | 2024-2025 | Barostim Neo System |
| Otsuka America Pharmaceutical, INC. | $18.29 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $9.62 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.